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Abstract 
Background: Peritoneal infections of enteric origin (EntP) have been classically investigated using partial strategies, 
focused on particular subgroups of microorganisms. A more comprehensive approach may facilitate the definition of 
the nomenclature and clinical presentation of these infections.  
Objectives: To investigate the clinical presentation and outcomes of a full spectrum of EntP, with a particular interest 
in the comparison between single-organism and polymicrobial infections.  
Method: Following an observational design, we investigated 165 single-organism and 83 polymicrobial peritonitis 
episodes with isolation of at least 1 enteric bacteria (Enterobacteriaceae, Enterococcus spp. and/or intestinal 
anaerobics). We compared the risk of treatment failure for these 2 types of infection and explored the significance of 
the isolation of specific microorganisms and of their antibacterial susceptibility patterns.  
Results: Polymicrobial EntP was associated with higher rates of hospitalization, more changes to initial antibiotic 
therapy, more surgical explorations, and higher mortality and treatment failure rates than monobacterial EntP. 
However, stratified and multivariate analyses revealed that the burden of these differences rested on the isolation of 
intestinal anaerobics (odds ratio [OR] 12.05, 95% confidence interval [CI] 2.53–31.09, p < 0.001) and/or 
Enterococcus faecium (OR 3.37, 95% CI 1.02–11.30, p = 0.046), while other polymicrobial infections were more 
comparable with single-organism peritonitis, except for even higher mortality rates in the former group. Lower 
antibiotic susceptibility of the isolations (OR 1.18, 95% CI 0.51–2.70, p = 0.70) did not perform as a predictor of 
treatment failure.  
Conclusion: A comprehensive approach to peritoneal infections by intestinal microorganisms may provide a focused 
perspective of the clinical presentation and outcomes of these complications of peritoneal dialysis.  
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Peritoneal infections with an enteric origin (EntP) represent one of the most feared complications of 
peritoneal dialysis (PD), due both to the difficulties of determining an accurate  diagnosis and 
management, and to their significant complication rates, including mortality and PD technique failure 
(1,2). One important limitation at the time of approaching EntP is the lack of a standardized definition of 
these infections. In fact, current International Society for Peritoneal Dialysis (ISPD) guidelines do not 
even attempt a comprehensive approach to the diagnosis and management of EntP (3). Overall, only 
peritoneal infections caused by at least 2 different microorganisms of intestinal origin or 1 enteric 
anaerobic bacteria are universally recognized as EntP (3). Similar considerations may apply for peritonitis 
caused by 1 single enteric bacterium (including Enterobacteriaceae and Enterococcus spp.), but direct 
categorization of these infections as EntP may be more controversial because, in these cases, alternative 
pathways of contamination are feasible. The convenience of categorizing monobacterial together with 
polymicrobial peritonitis by intestinal microorganisms as EntP depends largely on the compared clinical 
presentation, management, and outcomes of these infections. However, there are surprisingly few studies 
addressing this question (4,5). In particular, the influence of clinical and microbiologic factors, including 
the etiologic agents and their antibiotic susceptibility patterns, on the presentation of EntP has not been 
sufficiently investigated.  
 
We have undertaken an observational study, based on a comprehensive approach to the clinical 
presentation and outcomes of peritoneal infections caused by a full spectrum of microorganisms of 
presumed enteric origin. Our main objective was to compare the outcomes of single-organism and 
polymicrobial peritonitis, paying particular attention to the significance of the isolation of specific 
microorganisms. 
METHOD 
GENERAL DESIGN 
Following an observational, retrospective design, we analyzed the clinical presentation of peritoneal 
infections with a presence of at least 1 microorganism of presumed enteric origin, diagnosed in our center 
between January 1990 and December 2016. Primary objectives of our analysis included a comparison of 
the clinical presentation of monobacterial (MEntP) and polymicrobial (PEntP) infections, as well as 
exploring potential markers of a complicated clinical course in these 2 groups of infections. 
 
The study was carried out in a tertiary university hospital attending to 100 to 120 patients on PD per 
year, during the whole study period. The main study variable was the single-organism or polymicrobial 
character of peritoneal infections by intestinal microorganisms. The main outcome was a composite 
variable reflecting treatment failure (see below). We also analyzed a wide set of control variables with a 
potential impact on the presentation or outcome of these infections. 
 
The present study followed the ethical principles for medical research included in the declaration of 
Helsinki, and complied with the requirements of our center for observational, retrospective studies. We 
requested and obtained oral consent for the study from all patients available at the initiation of the study.  
  
STUDY POPULATION 
The main subjects of our analysis were episodes of peritoneal infection with the presence of at least 1 
intestinal microorganism recorded during the aforementioned period, including: 
 
1) Monobacterial infections caused by microorganisms with a usual enteric origin, including 
Enterococcus spp., Enterobacteriaceae, and intestinal anaerobics. 
2) PEntP, defined by the isolation of 2 or more microorganisms, at least 1 of them having a presumed 
enteric origin. 
 
We considered only cases with complete clinical records, including a follow-up until the end of the 
study period or PD drop-out for any reason (switch to hemodialysis, kidney transplant, or death).  
 
We excluded from analysis the following instances:  
 
 Infections with a rampant surgical background, defined by an immediate (first 24 hours) diagnosis 
and/or outcome. Consequently, we excluded the so-called abdominal catastrophes (mesenteric 
thrombosis, overt intestinal perforation, and other surgical processes undergoing a straight diagnosis 
and management) 
 PEntP with a primary isolation of yeasts or filamentous fungi, due to their specific clinical 
presentation and management. On the other hand, we considered cases with a secondary isolation 
(reinfection) of these microorganisms 
 MEntP with simultaneous catheter exit-site or tunnel infection by the same etiologic agent (catheter-
dependent infections) 
 Infections by microorganisms with a possible, but not unequivocal, enteric origin, including non-
fermenting gram-negative bacteria or Streptococcus spp. 
 Relapses of EntP, which were categorized as a part of the original episode 
STUDY VARIABLES 
The main study variable was the single-organism or polymicrobial nature of EntP. Secondary study 
variables included the isolation of Escherichia coli, Enterococcus spp., or anaerobics as etiologic agents, 
as well as the antibacterial susceptibility patterns of the isolations. The latter were categorized for analysis 
according to the minimal inhibitory concentrations (MIC) for vancomycin (Enterococcus spp.), 
cefotaxime, ceftazidime, imipenem-cilastatin, gentamycin, and ciprofloxacin (gram-negative bacteria). 
We categorized the antibiotic resistance pattern of gram-negatives as low (susceptible) when the iso-
lations was resistant to, at most, 1 of the 5 aforementioned antibiotics; intermediate susceptibility was 
defined by resistance to 2 to 3 antibacterials. Multiresistance was defined by non-susceptbility to at least 4 
of the tested antibacterials. Regarding enterococci, we observed no single instance of overt resistance to 
vancomycin, and we categorized as intermediate resistance a MIC > 2 mcg/mL. The antibiotic 
susceptibility patterns of anaerobic bacteria were not routinely tested. In the case of PEntP, overall 
antibacterial susceptibility was categorized according to the less favorable pattern of resistance. 
 
The main outcome variable was treatment failure, defined by at least 1 of the following 3: peritoneal 
catheter removal, transfer to hemodialysis for at least 3 months after the infection, or death related to 
peritonitis (demise for any reason during hospital admission or within 30 days after initiation of the 
episode). Secondary outcome variables included: hospitalization, number of days with a documented 
peritoneal inflammatory response (delay to the first dialysate leukocyte count < 100/mm3 or to catheter 
removal), changes to the initial empiric antibiotic therapy, abdominal surgical exploration, and relapse 
and reinfection, according to the ISPD criteria (3).  
The main control variables included age, gender, presence of diabetes, time on PD at the time of the 
infection, number of major comorbidities, previous immunosuppressive therapy, malnutrition (subjective 
global assessment), and the latest plasma albumin level before the episode of infection (median 2 months, 
range 0 – 4).  
DEFINITION OF VARIABLES AND CLINICAL PROCEDURES 
The general diagnosis of peritoneal infection, as well as the nomenclature related to its outcomes, 
complied with the ISPD standards (3). In our center, hospital admission for peritoneal infection is 
indicated for 3 main reasons: high-risk patients, complicated infections (aggressive clinical presentation, 
refractoriness to appropriate antibiotic therapy), or isolation of microorganisms demanding in-center 
management (e.g. yeasts).  
 
In our center, the protocol for initial treatment of peritoneal infections has been modified over time, 
according to variations in the antibiotic susceptibility patterns of the isolations obtained. Between 1990 
and 2007, initial therapy was based on intraperitoneal ciprofloxacin. After a progressive increase in the 
rates of resistance of coagulase-negative staphylococci (but not of gram-negative bacteria) in 2007, we 
moved to a new schedule based on intravenous vancomycin and intraperitoneal cefotaxime, which still 
stands. After the initial diagnosis of peritonitis, we perform clinical, cytologic, and bacteriologic controls 
every 48 hours until full remission of the infection. Antibiotic therapy is adapted to the susceptibility 
patterns of the isolations and maintained for a minimum of 2 weeks, following the ISPD 
recommendations (3). Usual changes to the initial treatment after isolation of gram-negatives include 
addition of a second antibacterial (more commonly an aminoglycoside) or switch to a carbapenem, on an 
individual basis. Antibiotic susceptibility is tested using a standard MIC method. 
 
Between 1990 and 2010 the indication for abdominal imaging was individualized. Since 2010, we 
perform routine computed tomography (CT) scans on all patients with peritoneal infection and isolation 
of at least 1 enteric microorganism. The indications for exploratory laparoscopy/laparotomy remain 
individualized. 
DATA ANALYSIS AND STATISTICS 
Numeric variables are presented as mean values (standard deviation), and categorical variables as the 
number of cases (%). Univariate comparisons between MEntP and PEntP were produced using 2-tailed 
Student’s t-test, ANOVA (Scheffé) (numeric) and χ2 distribution (categorized). We first compared the 
demographic, clinical, and evolutionary patterns associated with MEntP and PEntP. We performed 
subanalyses to disclose the impact of the specific isolations of Escherichia coli, Enterococcus spp., and 
anaerobic bacteria. Finally, we investigated the significance of the antibacterial susceptibility patterns for 
the outcome of the infections. 
 
We applied stepwise logistic regression analysis to investigate predictors of the main outcome 
variable (treatment failure). A preliminary, exploratory analysis identified gender, plasma albumin, and 
time on dialysis at the moment of the infection as variables with a potential association with the main 
outcome. Subsequently, we investigated the adjusted effect of the following primary and secondary study 
variables on the risk of treatment failure: single-organism versus polymicrobial infection, isolation of 
specific bacteria (Escherichia coli, Enterococcus spp., and anaerobics), and the antibiotic susceptibility 
patterns of the isolations. We managed the latter variable binarily (higher/lower susceptibility) due to a 
low proportion of highly multiresistant strains (see Results). 
 
We performed statistical analysis with the help of the SPSS 19.0 software (SPSS, Chicago, IL, USA).  
RESULTS 
OVERVIEW 
We recorded 1,066 episodes of peritoneal infection during the study period, including 800 (75.0%) 
caused by a single microorganism, 153 (14.4%) by 2 or more microorganisms, and 113 (10.6%) culture-
negative cases. The series included 270 episodes of peritoneal infection with isolation of enteric 
microorganisms. Of these, we excluded from analysis 22 episodes due to incomplete clinical records (n = 
5), simultaneous catheter exit-site infection by the same bacteria (n = 9), rampant surgical nature of the 
event (n = 6), or primary isolation of yeasts in a setting of PEntP (n = 2). In total, we analyzed 165 
episodes of MEntP and 83 episodes of PEntP.  
 
The etiologic agents of infection are shown in Table 1, while Table 2 compares the demographic, 
clinical, and microbiologic characteristics of MEntP and PEntP at presentation. Patients suffering PEntP 
were marginally older, without other apparent differences between the groups.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
b Clostridium perfringens, Bacteroides fragilis and unidentified 
anaerobic gram-negative. 
  
TABLE 1. Etiologic Agents of Peritoneal Infection 
 MEntP n=165 PEntP n=83 
   
Enterococcus spp. 
E. faecalis 
E. faecium 
Other 
33 (20.0) 
26 (15.8) 
5 (3.0) 
2 (1.2) 
29 (34.9) 
17 (20.5)a 
11 (13.3)a 
2 (2.4) 
Escherichia coli 59 (35.7) 46 (55.4) 
Klebsiella spp. 28 (17.0) 11 (13.3) 
Serratia spp. 14 (8.5) 3 (3.6) 
Enterobacter spp. 13 (7.9) 6 (7.2) 
Proteus spp. 5 (3.0) 6 (7.2) 
Morganella spp. 2 (1.2) 11 (13.3) 
Citrobacter spp. 3 (1.8) 4 (4.8) 
Other enteric gram-negatives 5 (3.0) 3 (3.6) 
Enteric anaerobics 3 (1.8)b 20 (24.1) 
Non-fermenting gram-negatives — 5 (6.1) 
Other non-enteric gram-negatives — 2 (2.4) 
Streptococcus spp. — 31 (37.3) 
Staphylococcus spp. — 15 (18.1) 
Other non-enteric gram-positives — 1 (1.2) 
   
MEntP = single-organism enteric peritonitis; PEntP = polymicrobial 
enteric peritonitis. 
Figures denote number of episodes (%). 
a E. faecalis and E. faecium coexisted in 1 case. 
TABLE 2. Demographic and Microbiologic Differences According to Study Group 
 MEntP PEntP p value 
    
N 165 83  
Age (years) 62.9 (14.2) 66.1 (11.6) 0.058 
Males/females (%) 61.8/38.2 55.4/44.6 0.31 
Time on PD (months) 24.0 (19.2) 25.8 (24.2) 0.58 
Modality of PD (CAPD/automated PD) (%) 67.3/32.7 67.5/32.5 0.69 
Diabetes (%) 31.5 25.3 0.35 
Comorbidity score 2.91 (2.51) 2.44 (2.27) 0.14 
Previous kidney transplant (%) 6.7 3.6 0.39 
Previous/current immunosuppressives (%) 12.1 7.3 0.28 
Malnutrition (%) 14.5 4.8 0.097 
Plasma albumin (g/L) 36.1 (5.5) 36.8 (5.4) 0.80 
Antibiotic resistance patterns (%)a 
Susceptible 
Intermediate resistance 
Multiresistance 
75.3 
23.4 
1.3 
67.1 
28.6 
4.3 
0.24 
 
 
MEntP = single-organism enteric peritonitis; PEntP = polymicrobial enteric 
peritonitis; PD = peritoneal dialysis; CAPD = continuous ambulatory PD. 
Figures denote mean values (standard deviation)(numeric variables) or % (categorical 
variables). 
a Enterococcus spp. and enteric gram-negatives. 
The MIC90 values for the isolated gram-negative bacteria were 32 mcg/mL (cefotaxime), 4 mcg/mL 
(ceftazidime), 4 mcg/mL (imipenem-cilastatin), 1 mcg/mL (ciprofloxacin) and 8 mcg/mL (gentamycin), 
respectively. Vancomycin MIC90 for enterococci was 2 mcg/mL. We recorded 3 instances of extended-
spectrum beta-lactamase-producing Enterobacteriaceae, and no further analysis was dedicated to this 
particular subset. 
COMPARED OUTCOMES OF MEntP AND PEntP 
Table 3 compares the clinical presentation and outcomes of MEntP and PEntP. Some of the 
differential features could be, at least partly, a consequence of the concerns raised by the isolation of 
polymicrobial flora. Thus, PEntP was associated with more hospitalizations, longer in-hospital stays, and 
more frequent changes to the initial antibiotic therapy. In addition, surgical exploration was more 
frequently indicated in the presence of PEntP. Most importantly, mortality and treatment failure rates 
were clearly higher in these cases. On the other hand, relapses were more frequent in MEntP. 
  
TABLE 3Clinical Presentation and Outcomes According to Type of Infection 
 MEntP PEntP p value 
    
N 165 83  
Hospital admission (%) 30.3 48.2 0.012 
No. of days of admission  5.6 (13.5) 15.2 (30.7) 0.008 
No. of days with peritoneal inflammation 6.0 (3.7) 5.7 (3.3) 0.64 
Peritoneal cell count at baseline (per mm3) 3,566 (6,303) 2,841 (2,883) 0.63 
% of neutrophils at baseline 76.9 (13.2) 77.1 (16.1) 0.93 
Changes to initial antibacterial therapy (%) 
Did not change 
Torpid/refractory infection 
In vitro resistance 
Late isolations 
Systemic compromise 
Relapse under treatment 
 
55.8 
21.1 
17.6 
2.4 
1.2 
1.8 
 
36.8 
27.6 
15.8 
17.1 
1.3 
1.3 
0.001 
Peritoneal catheter removed (%) 17.0 25.3 0.15 
Relapse (%) 18.8 7.2 0.048 
Reinfection (%) 
Other bacteria 
Yeasts 
4.8 
2.4 
1.2 
2.4 
0.21 
Surgical exploration (%) 3.0 18.0 0.001 
Final outcome (%) 
PD continued for at least 3 months 
Drop-out to hemodialysis 
Death 
87.3 
5.4 
7.3 
66.3 
13.3 
20.5 
0.001 
Treatment failurea (%) 20.0 37.3 0.003 
 
 
MEntP = single-organism enteric peritonitis; PEntP = polymicrobial enteric peritonitis; PD 
= peritoneal dialysis.  
Figures denote mean values (standard deviation)(numeric variables) or % (categorical 
variables). 
a Demise and/or drop-out to hemodialysis and/or catheter removed. 
Overall, surgical exploration was undertaken in 21 patients. In 8 cases (3 MEntP and 5 PEntP), no 
evident cause for the infection was identified (“white” laparotomies). Diagnoses during the remaining 
explorations included acute diverticulitis (n = 4), bowel perforation in a setting of intestinal ischemia (n = 
3), acute cholecystitis (n = 3), acute appendicitis (n = 2), and acute pancreatitis (n = 1). Surgical 
exploration was more frequently performed in PEntP than in MentP (Table 3), as well as when anaerobic 
bacteria were isolated (47.8% vs 4.4%, p < 0.001). Remarkably, 3 “white” laparotomies occurred in 
patients suffering PEntP with the presence of anaerobics. 
 
On univariate analysis, the incidence of treatment failure was 29.8% when Escherichia coli was 
isolated, as compared with 27.1% in the opposite case (p = 0.64). The presence of Enterococcus spp. 
overall did not result in different rates of this outcome (28.3% vs 28.1%, p = 0.98). On the other hand, 
isolation of Enterococcus faecium portended a complicated clinical course (50.0% vs 26.4%, p = 0.024). 
The most consistent univariate predictor of treatment failure was isolation of anaerobic bacteria (78.9% vs 
24.2%, p < 0.001). 
 
Table 4 displays the clinical presentation and outcomes of MEntP and PEntP, after stratification for 
the presence or absence of anaerobic bacteria in the case of PEntP. Under these conditions, the outcomes 
of MEntP and PEntP without anaerobics were more comparable, although some differences persisted, 
including a higher rate of mortality in the latter group. 
  
TABLE 4. Clinical Presentation and Outcomes According to Type of Infection and Presence or Absence of Anaerobicsa 
 MEntP, no anaerobics PEntP, no anaerobics PEntP with anaerobics 
    
N 162 63 20 
Hospital admission (%) 28.4 39.1 95.0 
No. of days of admission  5.1 (11.3) 7.3 (18.6) 42.5 (44.7)c 
No. of days with peritoneal inflammation 6.0 (3.7) 5.6 (3.4) 6.3 (3.4) 
Baseline peritoneal cell count (per mm3) 3556 (6297) 2812 (2542) 2977 (3771) 
% of neutrophils at baseline 76.8 (13.2) 77.4 (16.3) 75.5 (15.8) 
Changes to initial antibacterial therapy (%)  
Did not change 
Torpid/Refractory infection 
In vitro resistance 
Late isolations 
Systemic compromise 
Relapse under treatment 
 
56.8 
21.0 
17.3 
1.9 
1.2 
1.8 
 
41.4d 
24.1 
19.0 
13.8 
1.7 
0 
 
10.0c 
55.0 
5.0 
25.0 
0 
5.0 
Peritoneal catheter removed (%) 17.0 14.1 65.0c 
Relapse (%) 18.8 6.3e 10.0 
Reinfection (%) 
Other bacteria 
Yeasts 
 
4.8 
2.4 
 
0 
3.2 
 
5.0 
0 
Surgical exploration (%) 3.0 6.3 55.0c 
Final outcome (%) 
PD continued for >3 months 
Drop-out to hemodialysis 
Death 
 
88.3 
5.5 
6.2 
 
76.5 
6.3 
17.2f 
 
30.0c 
35.0c 
35.0c 
Treatment failureb (%) 19.8 25.3 80.0c 
 
 
MEntP = single-organism enteric peritonitis; PEntP = polymicrobial enteric peritonitis; PD = peritoneal dialysis.  
Figures denote mean values (standard deviation)(numeric variables) or % (categorical variables). 
a Data for monobacterial anaerobic infections (n=3) not presented. 
b Demise and/or drop-out to hemodialysis and/or catheter removed. 
c p<0.001 vs any other group. 
d p=0.012 vs monobacterial. 
e p=0.058 vs monobacterial. 
f p=0.022 vs monobacterial. 
Other differences not significant. 
MULTIVARIATE ANALYSIS 
Logistic regression analysis (Table 5) confirmed the isolation of anaerobic bacteria as the most 
consistent predictor of treatment failure. Our data also indicated that isolation of Enterococcus faecium 
may portend a similar prognosis. On the other hand, the influence of the number of isolations or the 
antibiotic resistance patterns of the causing microorganisms did not bear an independent impact on the 
general prognosis of the infections although, in the former case, data suggested a minor trend to a higher 
risk for PEntP than for MEntP. A secondary analysis did not disclose a different outcome in PEntP with 2 
(n = 59) versus 3 or more isolations (n = 24), after controlling for the presence of anaerobics and 
Enterococcus faecium (odds ratio [OR] 0.96, 95% confidence interval [CI] 0.30 – 3.07, p = 0.96). 
 
An analysis specifically oriented to the risk of peritonitis-related mortality disclosed that after 
controlling for other independent predictors of this outcome (age, plasma albumin, presence of 
anaerobics, and time on PD at infection), PEntP was associated with a higher risk of this event than 
MEntP (OR 3.38, 95% CI 1.27 – 9.03, p = 0.008). 
  
TABLE 5. Predictors of Treatment Failure: Multivariate, Logistic Regression Analysis 
Best model OR 95% CI p value 
    
Time on PD (per month) 1.04 1.03–1.06 0.001 
Plasma albumin (per 1 g/L) 0.92 0.86–0.99 0.017 
Anaerobics isolated (Ref. No) 12.05 2.53–31.09 0.001 
Enterococcus faecium isolated (Ref. No) 3.37 1.02–11.30 0.046 
Adjusted effect of primary study variables 
Polymicrobial infection (Ref. Monobacterial) 1.88 0.82–4.34 0.14 
Intermediate or low susceptibility of gram-negatives to antibacterials  
(Ref. High susceptibility) 
1.18 0.51–2.70 0.70 
Adjusted effect of secondary study variables 
Escherichia coli isolated (Ref. No) 1.11 0.52–2.50 0.78 
Enterococcus faecalis isolated (Ref. No) 0.85 0.41–1.78 0.66 
Vintage (Ref. infection 1990–2006) 0.79 0.36–1.72 0.55 
 
 
OR = odds ratio; CI = confidence interval; PD = peritoneal dialysis. 
First-order interaction terms not significant. 
DISCUSSION 
According to the results of our study, peritoneal infections caused by intestinal microorganisms 
resulted in significant rates of mortality, permanent drop-out to hemodialysis, and, in general, treatment 
failure. On the other hand, PEntP was associated with higher morbidity and mortality rates than MEntP. 
However, a detailed analysis of our data revealed that the adverse outcome of these infections was 
primarily associated with the isolation of specific microorganisms, namely anaerobic bacteria and 
Enterococcus faecium, while the single-organism or polymicrobial nature of the infections appeared to be 
consequential only in terms of peritonitis-related mortality. To our knowledge, this is the first study 
attempting to enclose the full spectrum of PD-related peritonitis by enteric microorganisms, as opposed to 
previous studies, which focused separately on infections by gram-negatives (5,6), Enterobacteriaceae (1), 
enterococci (7–9), or polymicrobial (enteric and non-enteric) peritonitis (4,5). 
 
Relatively few studies have addressed the significance of peritoneal infections by gram-negative 
bacteria in PD patients. Bunke et al. (6) compared 136 such episodes (after excluding infections by non-
fermenting gram-negatives), with 530 cases of peritonitis by gram-positives (including Enterococcus 
spp.). Gram-negatives were associated with a more severe prognosis than gram-positives, a difference 
which was particularly marked in the absence of a simultaneous catheter infection. Szeto et al. (1) 
investigated 210 episodes of monobacterial peritonitis by Enterobacteriaceae (including 37 catheter-
dependent episodes), confirming a severe prognosis for these infections. This study disclosed a high 
incidence of resistance to antibacterials in these cases, particularly in patients previously treated with 
antibiotics. Two more recent reports from the ANZDATA registry have come to similar conclusions 
(5,10). At least 2 studies investigating the risk profile for catheter removal due to peritonitis identified 
isolation of Enterobacteriaceae as an independent predictor of this outcome (11,12). Isolation of 
multiresistant strains of gram-negatives, including those producing extended beta-lactamases, may further 
complicate the management and outcome of these infections (13). 
 
Between 2 and 6% of the episodes of PD-related peritonitis are caused by enterococci (14). These 
typically enteric microorganisms are more frequently observed in polymicrobial infections, where they 
may be present in as many as 45% of the episodes (7), but can also present as single-organism peritonitis 
(8,9). Enterococci cause relatively serious infections, with significant rates of relapse, treatment failure, 
and even mortality (9). Species characterization may be relevant, at least regarding the 2 most common 
types, namely Enterococcus faecalis and Enterococcus faecium, because the latter was associated with 
more complicated antibiotic resistance patterns (14). In agreement with these contentions, our data 
indicated that isolation of Enterococcus faecium, but not Enterococcus faecalis, was a consistent predictor 
of treatment failure (Table 5). 
 The significance of PEntP has been a subject of limited attention in the past (15). Importantly, some 
relevant studies on gram-negative peritonitis excluded these infections from their analyses (1,6). The best 
information on this question appears to come from the ANZ setting (4,5,10). According to data from this 
registry, polymicrobial infections represent 13% of the total amount of peritonitis (10), do not present a 
well-defined risk profile, and was associated with increased rates of hospitalization, peritoneal catheter 
removal, PD drop-out, and mortality (4). However, these studies did not permit a clear differentiation 
between infections of enteric and non-enteric origin, although the presence of non-pseudomonal gram-
negative bacteria appeared to have a detrimental influence on outcomes (4). In addition, the proportion of 
cases with isolation of anaerobic bacteria was remarkably low in these studies (4,10). The reasons for this 
circumstance are not clear, but may suggest some type of bias at the time of data collection. To our 
knowledge, only a relatively small case series (10 episodes in 6 patients) has specifically addressed the 
issue of PD-related peritonitis with isolation of anaerobic bacteria (16). In this study, only 3 episodes 
appeared to present a background of overt abdominal disease, and antibacterial therapy alone was 
successful in 8 cases. 
 
Several considerations support the convenience of a comprehensive analysis of peritonitis by intestinal 
microorganisms. These infections seemingly share common origins and pathways of progression (micro- 
or macroscopic transmural contamination, hematogenous). This implies potentially homogeneous risk 
profiles and precipitating factors, a common diagnostic approach (including abdominal imaging and 
surgical exploration), and similar prevention and treatment strategies. The absence of this type of 
inclusive approach may have contributed to the paucity of advances in the prevention and management of 
these infections during the last decades (17). On the other hand, a significant limitation of this strategy is 
the possibility that, in some cases, these infections may originate from touch contamination or peritoneal 
catheter-related infection. This circumstance is more likely in MEntP than in PEntP, and the high risk of 
an adverse outcome in the presence of anaerobics observed in our study may be partly due to the higher 
likelihood of significant abdominal disease in these cases. Catheter-dependent cases may be reasonably 
screened with the help of a careful physical examination and abdominal wall ultrasound. Touch 
contamination is more difficult to discard, but it may be argued that presumption of an enteric origin (less 
favorable hypothesis) is the most conservative and sensible first-line approach to these cases. 
 
In our study, an exploratory laparotomy was commonly indicated in the presence of PEntP with 
isolation of anaerobic bacteria, but much less frequently in other settings of EntP (Table 4). Moreover, 
surgical exploration was negative in 38.1% of the cases in which it was undertaken, including 3 cases 
with a high suspicion of abdominal disease. These findings support the notions that surgical abdominal 
disease underlies a minority of EntP, but also that taking the decision to operate represents a major 
challenge in clinical practice. Given the dismal prognosis of surgical events in the absence of interven-
tion, the convenience of an exploratory laparotomy should always be considered during the course of 
EntP, particularly in 3 circumstances: PEntP with isolation of anaerobics, aggressive clinical presentation, 
or refractory clinical course (3).  
 
According to our data, relapse was significantly more frequent in MEntP than in PEntP (Table 3), 
which agrees with previous reports (5). The reasons for this finding are not clear, but the possibility of a 
methodologic bias should be considered, because mortality and technique failure (both more frequent in 
PEntP) represent competing risk events for relapse of infection. 
  
Our study presented significant limitations, including a single-center, retrospective design. The low 
number of multiresistant microorganisms limited the significance of our analysis for the influence of 
susceptibility to antibacterials on infection outcomes. Among its strengths, we emphasize that it repre-
sents a first comprehensive approach to PD-related peritonitis of enteric origin. Exclusion of primary 
fungal infections and abdominal catastrophes permitted a better focused, clinically oriented approach, 
because these subsets demand specific diagnostic and therapeutic approaches. The high quality of our 
database permitted a complete and rewarding analysis of the study population.  
 
In summary, peritoneal infections by enteric microorganisms result in significant rates of treatment 
failure, mortality, and permanent drop-out to hemodialysis. Polymicrobial peritonitis was associated with 
higher morbidity and mortality rates than single-organism infections, but an adverse outcome of these 
infections is primarily related to the presence of specific microorganisms, namely anaerobic bacteria and 
Enterococcus faecium. A comprehensive approach to peritoneal infections by intestinal gram-positive, 
gram-negative, and anaerobic microorganisms may help to define the clinical presentation, prognosis and 
treatment of these fearsome complications of PD. 
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